Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid Tumors - BeOne

Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid Tumors

BeOne Study ID

BGB-283-AU-001

ClinicalTrials.gov ID

NCT02610361

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents